Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 38Lung Neoplasms 9Adenocarcinoma of Lung 9NSCLC 5Brain Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 3Neoplasms 2Adenocarcinoma 2Triple Negative Breast Neoplasms 1Skin Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-Small-Cell Lung 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1Advanced Stage Non Small Cell Lung Cancer 1Advanced Non-small Cell Lung Cancer 1Advanced NSCLC With EGFR Mutation 1

Interventions

Oxaliplatin 4Gemcitabine 4Fluorouracil 3Capecitabine 3Tegafur 2Stents 2Radiofrequency Ablation 2Leucovorin 2Irinotecan 2toripalimab 1tislelizumab 1taxane 1surufatinib 1lenvatinib 1apixaban 1apatinib 1aldesleukin 1Urination 1Trastuzumab 1Tomography, X-Ray Computed 1Temozolomide 1Taxes 1Standard of Care 1Sorafenib 1S 1 (combination) 1Rivaroxaban 1Radiotherapy 1Polymerase Chain Reaction 1Platinum Compounds 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gallbladder Neoplasms × Gefitinib × Clear all
NCT02836847 2018-05-07

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
152 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡